Gayle King comes on the show to discuss the one universal female experience: Menopause. Gayle and Dr. Sharon talk about their shared histories of having conversations around menopause with Oprah and Michelle Obama. Gayle also shares what her experiences were like and why she regrets not doing Hormone Replacement Therapy. Plus, Gayle talks about being vibrant and alive past your 60's and why she wants to have the conversation about menopause on the show, since she knows many women who have suffered, felt ashamed, or have had their doctor's ignore their symptoms. Have questions? Submit them here.

The Second Opinion with Dr. Sharon is a production of Higher Ground.

Hosted by Dr. Sharon Malone.

Produced by Stella Hartmann.

Production Assistance by Franchesca Diaz.

Sound Design and Engineering by Ryan Kozlowski and Andrew Eapen.

Head over to Alloy Health, where Dr. Sharon Malone serves as Chief Medical Advisor, and discover why 95% of women who tried Alloy experienced menopause relief within just two weeks. Plus, as a special offer, use code TSO25 at checkout to receive $25 off your first order today.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Medical oncologist and author Dr. Elizabeth Comen joins to unpack the long history of how women’s bodies have been misunderstood and minimized in medicine. From the early days of male doctors who believed women were "small men" to the racial bias that shapes how Black women’s pain is treated. Dr. Sharon and Dr. Comen explore how these ideas still influence care today. Plus, both Dr. Sharon and Dr. Comen discuss the dynamics between oncologiists and their relationship to Hormone Replacement Therapy. Have questions? Submit them here.

Dr. Elizabeth Comen, M.D., has dedicated her medical career to saving the lives of women. An award-winning, internationally sought-after clinician and physician-scientist, Dr. Comen is a Medical Oncologist specializing in breast cancer and an Associate Professor of Medicine and the Co-Director of the Mignone Women’s Health Collaborative at NYU Langone Health. She earned her BA in the History of Science from Harvard College and her MD from Harvard Medical School, then completed her residency in Internal Medicine at Mount Sinai Hospital and her fellowship in oncology at Memorial Sloan Kettering Cancer Center. Her research has been published in prestigious scientific journals, including Nature, Cancer Cell, Journal of Clinical Oncology, and The Journal of National Cancer Institute. A tireless advocate for women’s healthcare, she is the author of the national best seller: All In Her Head: The Truth and Lies Early Medicine Taught Us About Women’s Bodies and Why It Matters Today.

The Second Opinion with Dr. Sharon is a production of Higher Ground.

Hosted by Dr. Sharon Malone.

Produced by Stella Hartmann.

Production Assistance by Franchesca Diaz.

Sound Design and Engineering by Ryan Kozlowski and Andrew Eapen.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

You probably have some idea of how medical cannabis affects your brain. But do you know the impacts of cannabis on women's health? Dr. Staci Gruber comes on the show to discuss the ins and outs of cannabinoids and its studied benefits! Learn how research on cannabis shows that it might help with endometriosis and menopause. Plus, Dr. Sharon shares her take on cannabis and asks all the questions you want answered.

Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Her research focuses on the application of neurocognitive models and brain imaging to characterize risk factors for substance abuse and psychiatric conditions. She has studied the impact of recreational cannabis use on the brain for over three decades using neurocognitive/clinical assessments, and multimodal brain imaging techniques. Her work has been the basis for national and international symposia, documentaries, and news stories, which ultimately helped inform public policy. Given the many inherent differences between recreational and medical cannabis users, Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND) in 2014, the first program designed to clarify the long-term impact of medical cannabis use. MIND supports projects that aim to address the impact of medical cannabis on important variables including cognition, brain structure/function, clinical state, quality of life, pain, sleep, and other health-related measures. As director of MIND, Dr. Gruber has generated major contributions to the field as the first to assess medical cannabis patients longitudinally, first to acquire neuroimaging data in medical cannabis patients, and as PI of the first clinical trial of a full-spectrum, high-cannabidiol (CBD) product, which she formulated to treat anxiety. Additional, novel clinical trials have been approved and are currently underway. Dr. Gruber also launched the Women’s Health Initiative at MIND (WHIM), the first cannabis-focused research program designed to address women’s health and disorders that disproportionately affect women.

Resources:

https://www.mcleanhospital.org/profile/staci-gruber

https://www.drstacigruber.com/whim

https://www.drstacigruber.com/post/npr-marijuana-rescheduling

The Second Opinion with Dr. Sharon is a production of Higher Ground.

Hosted by Dr. Sharon Malone.

Produced by Stella Hartmann.

Production Assistance by Franchesca Diaz and CJ Archerd.

Sound Design and Engineering by Ryan Kozlowski and Andrew Eapen.

Head over to Alloy Health, where Dr. Sharon Malone serves as Chief Medical Advisor, and discover why 95% of women who tried Alloy experienced menopause relief within just two weeks. Plus, as a special offer, use code TSO25 at checkout to receive $25 off your first order today.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.